These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 20010330

  • 1. Angiotensin blockade is associated with early graft dysfunction after live donor renal transplantation.
    Stevens KK, Patel RK, Clancy M, Jardine AG.
    Transplantation; 2010 Mar 27; 89(6):707-9. PubMed ID: 20010330
    [Abstract] [Full Text] [Related]

  • 2. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
    Jennings DL, Taber DJ.
    Ann Pharmacother; 2008 Jan 27; 42(1):116-20. PubMed ID: 18094340
    [Abstract] [Full Text] [Related]

  • 3. Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months.
    González Monte E, Andrés A, Polanco N, Toribio MJ, Santana R, Gutiérrez Martínez E, González J, Ramírez E, Hernández A, Morales E, Praga M, Morales JM.
    Transplant Proc; 2010 Oct 27; 42(8):2899-901. PubMed ID: 20970564
    [Abstract] [Full Text] [Related]

  • 4. Early renal transplantation after donor renal angiography affects initial graft function.
    Tutal E, Canver B, Can S, Colak T, Sezer S, Haberal M.
    Transplant Proc; 2012 Jun 27; 44(5):1227-30. PubMed ID: 22663990
    [Abstract] [Full Text] [Related]

  • 5. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA.
    Hemodial Int; 2009 Oct 27; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [Abstract] [Full Text] [Related]

  • 6. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
    Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF.
    Nephrol Dial Transplant; 2004 Nov 27; 19(11):2852-7. PubMed ID: 15466882
    [Abstract] [Full Text] [Related]

  • 7. Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation.
    Thilly N, Bayat S, Alla F, Kessler M, Briançon S, Frimat L.
    Clin Transplant; 2008 Nov 27; 22(4):439-46. PubMed ID: 18318741
    [Abstract] [Full Text] [Related]

  • 8. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul 27; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 9. No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients.
    Slowinski T, Diehr P, Kleemann P, Fritsche L, Renders L, Budde K, Hauser IA, Neumayer HH, Hocher B.
    Nephrol Dial Transplant; 2004 Nov 27; 19(11):2846-51. PubMed ID: 15353577
    [Abstract] [Full Text] [Related]

  • 10. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan 27; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of factors causing delayed graft function in live related donor renal transplantation.
    Sharma AK, Tolani SL, Rathi GL, Sharma P, Gupta H, Gupta R.
    Saudi J Kidney Dis Transpl; 2010 Mar 27; 21(2):242-5. PubMed ID: 20228507
    [Abstract] [Full Text] [Related]

  • 12. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
    Pérez-Flores I, Sánchez-Fructuoso A, Calvo N, Marques M, Anaya S, Ridao N, Rodríguez A, Barrientos A.
    Transplant Proc; 2007 Sep 27; 39(7):2123-4. PubMed ID: 17889112
    [Abstract] [Full Text] [Related]

  • 13. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M, Tarantino A, Berardinelli L, Finazzi S, Montagnino G, Rossini G, Scalamogna M, Cesana B, Ponticelli C.
    G Ital Nefrol; 2002 Sep 27; 19(1):49-54. PubMed ID: 12165946
    [Abstract] [Full Text] [Related]

  • 14. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B, Canver B, Gurlek Demirci B, Colak T, Ozdemir BH, Haberal M.
    Exp Clin Transplant; 2017 Feb 27; 15(Suppl 1):32-36. PubMed ID: 28260428
    [Abstract] [Full Text] [Related]

  • 15. Kidney transplantation in the United States.
    Cecka JM.
    Clin Transpl; 2008 Feb 27; ():1-18. PubMed ID: 19711510
    [Abstract] [Full Text] [Related]

  • 16. Assessment of kidneys procured from expanded criteria donors before transplantation.
    Domagala P, Kwiatkowski A, Perkowska-Ptasinska A, Wszola M, Panufnik L, Paczek L, Durlik M, Chmura A.
    Transplant Proc; 2009 Oct 27; 41(8):2966-9. PubMed ID: 19857651
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP, Patton PR, Meier-Kriesche HU, Li Q, Shenkman B, Fujita S, Reed A, Hemming AW, Kim RD, Howard RJ.
    Clin Transpl; 2005 Oct 27; ():101-9. PubMed ID: 17424728
    [Abstract] [Full Text] [Related]

  • 18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 27; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for delayed graft function defined as need for dialysis or failure of creatinine to fall by 10% in the first 24 hours after transplant.
    Stratopoulos C, Roberts IS, Brockmann J, Zilvetti M, Muthusamy A, Vaidya A, Sinha S, Friend PJ.
    Exp Clin Transplant; 2008 Mar 27; 6(1):37-41. PubMed ID: 18405243
    [Abstract] [Full Text] [Related]

  • 20. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr 27; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.